21 CFR 814.80 - General

Cite as21 CFR 814.80
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
111 practice notes
  • Blanco v. Baxter Healthcare Corp., No. G038255.
    • United States
    • California Court of Appeals
    • January 11, 2008
    ...specifications may be changed in [a] way that affects safety and effectiveness only with FDA's authorization"]; see also 21 C.F.R. §§ 814.39, 814.80, 814.82, 814.84.) The PMA process has been described as "rigorous," requiring "[manufacturers [to] submit detailed information regarding the s......
  • Hawkins v. Medtronic, Inc., Case No. 1:13–CV–00499 AWI SKO.
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Eastern District of California
    • November 20, 2014
    ...‘misbranding’ of medical devices, which includes either misleading labeling or misleading advertising of the medical device, and 21 C.F.R. § 814.80 prohibits Defendants from advertising the INFUSE® Device for uses beyond what is provided in the PMA approval)2 ; Hawkins, 2014 WL 346622 at *7......
  • Mears v. Marshall
    • United States
    • Court of Appeals of Oregon
    • October 25, 1995
    ...or advertise the device "in a manner inconsistent with any conditions to approval specified in the PMA approval order for the device." 21 CFR § 814.80. With only minor exceptions, the manufacturer must also submit a PMA supplement for FDA review and approval before making changes that affec......
  • McLaughlin v. Bayer Corp., CIVIL ACTION NOS. 14-7315
    • United States
    • United States District Courts. 3th Circuit. United States District Court (Eastern District of Pennsylvania)
    • March 22, 2016
    ...prohibit a device from being labeled, advertised, or distributed in a manner inconsistent with any condition of approval in the PMA. See21 C.F.R. 814.80 (prohibiting a device from being labeled, advertised, or distributed in a manner inconsistent with any condition of approval in the PMA). ......
  • Request a trial to view additional results
112 cases
  • Blanco v. Baxter Healthcare Corp., No. G038255.
    • United States
    • California Court of Appeals
    • January 11, 2008
    ...specifications may be changed in [a] way that affects safety and effectiveness only with FDA's authorization"]; see also 21 C.F.R. §§ 814.39, 814.80, 814.82, 814.84.) The PMA process has been described as "rigorous," requiring "[manufacturers [to] submit detailed information regarding the s......
  • Hawkins v. Medtronic, Inc., Case No. 1:13–CV–00499 AWI SKO.
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Eastern District of California
    • November 20, 2014
    ...‘misbranding’ of medical devices, which includes either misleading labeling or misleading advertising of the medical device, and 21 C.F.R. § 814.80 prohibits Defendants from advertising the INFUSE® Device for uses beyond what is provided in the PMA approval)2 ; Hawkins, 2014 WL 346622 at *7......
  • Mears v. Marshall
    • United States
    • Court of Appeals of Oregon
    • October 25, 1995
    ...or advertise the device "in a manner inconsistent with any conditions to approval specified in the PMA approval order for the device." 21 CFR § 814.80. With only minor exceptions, the manufacturer must also submit a PMA supplement for FDA review and approval before making changes that affec......
  • McLaughlin v. Bayer Corp., CIVIL ACTION NOS. 14-7315
    • United States
    • United States District Courts. 3th Circuit. United States District Court (Eastern District of Pennsylvania)
    • March 22, 2016
    ...prohibit a device from being labeled, advertised, or distributed in a manner inconsistent with any condition of approval in the PMA. See21 C.F.R. 814.80 (prohibiting a device from being labeled, advertised, or distributed in a manner inconsistent with any condition of approval in the PMA). ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT